What C65 covers · when clinicians use it
ICD-10 code C65 identifies Malignant neoplasm of renal pelvis in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply C65 when an encounter's findings match the Malignant neoplasm of renal pelvis description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify C65 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for C65 and is a coding reference, not clinical, diagnostic, or billing advice.
C65 refers to Malignant neoplasm of renal pelvis, a group of cancers that affect the urinary system, including the kidney, ureter, bladder, and associated structures. These cancers often require imaging and biopsy for diagnosis and may present with urinary symptoms or systemic signs. ICD10 coding ensures accurate medical records, reimbursement, and cancer registry entry.
Symptoms
- Hematuria – Blood in the urine is a hallmark sign
- Flank or abdominal pain – Especially in kidney or ureteral tumors
- Frequent urination – Common with bladder tumors
- Burning sensation – During urination or persistent discomfort
- Pelvic pain – Indicative of advanced or spreading disease
- Fatigue and weight loss – Seen in late-stage cancers
- Urinary retention – Can result from tumor obstruction
Diagnosis
Diagnosis of Malignant neoplasm of renal pelvis involves urinalysis, imaging studies (ultrasound, CT urogram, MRI), cystoscopy, and biopsy. In some cases, cytology or tumor marker tests are used. Early detection through hematuria workups can improve prognosis, especially for bladder and kidney cancers.
ICD10 Code Usage
ICD10 code C65 is used by urologists, oncologists, and coders to accurately classify urinary tract cancers in clinical documentation and billing. It supports insurance claims, national cancer databases, and patient outcome tracking for genitourinary cancers.
Related Codes
- C64 – Malignant neoplasm of kidney, except renal pelvis
- C66 – Malignant neoplasm of ureter
- C67 – Malignant neoplasm of bladder
- C68 – Malignant neoplasm of other and unspecified urinary organs
FAQs
Q1: What is ICD10 code C65?
A: This code refers to Malignant neoplasm of renal pelvis, used in medical records and billing systems to document urinary tract cancers.
Q2: What causes these cancers?
A: Risk factors include smoking, occupational exposures, chronic infections, and family history.
Q3: How are they treated?
A: Treatment may involve surgery, immunotherapy, chemotherapy, radiation, or a combination depending on type and stage.
Q4: Can they be detected early?
A: Yes, particularly bladder cancer through hematuria evaluation or routine urology screening in high-risk groups.
Q5: Are they common?
A: Bladder and kidney cancers are relatively common, particularly in older adults.
Conclusion
ICD10 code C65 is crucial for the diagnosis and management of Malignant neoplasm of renal pelvis. Accurate documentation ensures timely intervention, facilitates epidemiologic tracking, and supports billing and treatment approvals. It plays a key role in improving patient outcomes in urinary tract oncology.